Sam Carter
 | This article is a stub. |
Sam Carter or Samuel Carter is an advocate and a patient with myalgic encephalomyelitis.
Talks and interviews[edit | edit source]
Letters[edit | edit source]
- 2010, FINE trial for CFS. Both significant and small?[1]
- 2012, A valedictory dispatch from the Psychosocial School?[2]
- 2013, Letter to the Editor: ‘Recovery from chronic fatigue syndrome after treatments given in the PACE trial’: recovery or remission?[3]
- 2016, Exploring changes to PACE trial outcome measures using anonymised data from the FINE trial[4]
Online presence[edit | edit source]
- Website/Blog
- YouTube
See also[edit | edit source]
Learn more[edit | edit source]
References[edit | edit source]
- ↑ Carter, Sam (June 9, 2010). "FINE Trial for CFS: Both significant and small?". BMJ. 340: c2988. doi:10.1136/bmj.c2988. ISSN 0959-8138. PMID 20534659.
- ↑ Carter, Sam (June 9, 2012). "A valedictory dispatch from the Psychosocial School? | Rapid Responses to articles". The BMJ. Retrieved January 29, 2019.
- ↑ Carter, Samuel (July 19, 2013). "Letter to the Editor: 'Recovery from chronic fatigue syndrome after treatments given in the PACE trial': recovery or remission?". Psychological Medicine. 43 (8): 1787–1788. doi:10.1017/S0033291713001268. PMID 23866112.
- ↑ Carter, Sam (February 15, 2016). "Exploring changes to PACE trial outcome measures using anonymised data from the FINE trial". Psychological Medicine. Archived from the original on February 18, 2018.
BMJ The BMJ (previously the British Medical Journal) is a weekly peer-reviewed medical journal.
The information provided at this site is not intended to diagnose or treat any illness.
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history.
